Volume 44, Issue 10 pp. 1657-1662
DEVICES

Severity of spleep apnea syndrome and life-threatening tachyarrhythmias in patients with implantable cardioverter defibrillator

Gianluigi Bencardino MD, PhD

Corresponding Author

Gianluigi Bencardino MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Correspondence

Gianluigi Bencardino,MD, PhD, Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Email: [email protected]

Search for more papers by this author
Nicola Vitulano MD, PhD

Nicola Vitulano MD, PhD

Division of Cardiology, Miulli General Hospital, Acquaviva delle Fonti, Italy

Search for more papers by this author
Antonio Bisignani MD, PhD

Antonio Bisignani MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Search for more papers by this author
Francesca Augusta Gabrielli MD, PhD

Francesca Augusta Gabrielli MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Search for more papers by this author
Gemma Pelargonio MD, PhD

Gemma Pelargonio MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Search for more papers by this author
Maria Lucia Narducci MD, PhD

Maria Lucia Narducci MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Search for more papers by this author
Francesco Perna MD, PhD

Francesco Perna MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Search for more papers by this author
Gaetano Pinnacchio MD, PhD

Gaetano Pinnacchio MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Search for more papers by this author
Gianluca Comerci MD, PhD

Gianluca Comerci MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Search for more papers by this author
Gaetano Antonio Lanza MD, PhD

Gaetano Antonio Lanza MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Search for more papers by this author
Massimo Massetti MD, PhD

Massimo Massetti MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Search for more papers by this author
Filippo Crea MD, PhD

Filippo Crea MD, PhD

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Search for more papers by this author
First published: 27 July 2021

Abstract

Background

Sleep apnea syndrome (SAS) has been reported to be associated with a higher incidence of ventricular arrhythmias. The aim of this study was twofold: (1) to investigate whether in SAS patients receiving an implantable cardioverter defibrillator (ICD) the severity of SAS was associated with the occurrence of ventricular arrhythmias; (2) to assess whether changes in nocturnal apnoic/hypopnoic episodes may favor the occurrence of life-threatening arrhythmias, that is, sustained ventricular tachycardia (VT)/fibrillation (VF), requiring ICD intervention.

Methods

We enrolled 46 patients with documented SAS at polysomnography (apnea/hypopnea index [AHI] > 5) who also had a left ventricle ejection fraction (LVEF) < 35% and, according to primary prevention indications, implanted an ICD (Boston Scientific Incepta) able to daily monitor apnoic/hypopnoic episodes occurring during sleep. Patients were followed at 3-month intervals.

Results

At a mean follow-up of 18 months, 21 episodes of sustained VT/FV requiring ICD intervention were documented in eight patients (17.4%). Baseline AHI was significantly higher in patients with compared to those without ICD intervention. ICD interventions, however, were not preceded by any worsening of apnoic/hypopnoic episodes. The respiratory disturbance index (RDI) of the week during the event, indeed, was not different from that recorded during the previous 2 weeks (25.4 ± 11, 25.6 ± 10 and 25.1 ± 10, respectively; p = .9).

Conclusions

In patients with SAS who received an ICD for primary prevention of sudden death, those with ICD interventions showed a more severe form of the disease at baseline. ICD interventions, however, were not preceded by any significant changes in SAS severity.

CONFLITCS OF INTEREST

The author declares no conflict of interest, financial, or otherwise.

DATA AVAILABILITY STATEMENT

The data underlying this article are available from the corresponding author on reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.